Siqing Yu, F. Hoffmann-La Roche (E);
Bjoern Titz, F. Hoffmann-La Roche (E);
Mahnaz Parian-Scherb, F. Hoffmann-La Roche (E);
Isabel Bachmeier, F. Hoffmann-La Roche (E);
Philip Enders, F. Hoffmann-La Roche (F);
Lebriz Altay, AbbVie (R), Apellis (R), Bayer (R), F. Hoffmann-La Roche (F), F. Hoffmann-La Roche (R), Novartis (R);
Michael Koss, F. Hoffmann-La Roche (C);
Siamak Ansari Shahrezaei, AbbVie (C), Apellis (C), Bayer (F), Bayer (C), F. Hoffmann-La Roche (F), F. Hoffmann-La Roche (C), Novartis (C);
Justus Garweg, AbbVie (C), Bayer (C), F. Hoffmann-La Roche (C), Novartis (C);
Carl Glittenberg, F. Hoffmann-La Roche (E);
Cathy Cukras, F. Hoffmann-La Roche (E);
Andreas Maunz, F. Hoffmann-La Roche (E);
Sascha Fauser, F. Hoffmann-La Roche (E)